Life Science Invest
Investing in the future
Aktuellt
Sweden’s largest life science business angel network goes Nordic and raises additional capital to support Nordic research companies
Press Release – January 2026 Life Science Invest’s sixth co-investment company, LSI Zeta, has raised EUR 2,9 million from 35 Nordic business angels with broad expertise in life science. The company will invest in around ten early-stage life science companies in the...
LSI Epsilon invest in Abarceo Pharma
We are happy to introduce LSI Epsilons 9th investment Abarceo Pharma AB, a pre-clinical stage company, developing a platform for the treatment of mitochondrial diseases, with an initial focus on Type 2 Diabetes (T2D).We look forward to work closely with Adam Bruce,...
LSI Epsilon invest in SampleFacts
So excited to introduce our 8th investment. SampleFacts is reinventing blood 🩸 sampling by separating blood and plasma instantly. We look forward to work closely with Maryam Poorafshar, Kristina Svensson, Frida Ekholm, Ulf Landegren, Jon-Sverre Schanche and rest of...
Investment strategy
There are many start-up companies within Life Science. We cannot evaluate them all, so we focus on finding companies within our niche. Which companies, then, are of interest to us?
Our angels
Life Science Invests angels have very broad and deep experience within Life Science.
